Phase II Study of Ramucirumab and Docetaxel for Previously Treated Non-Small Cell Lung Cancer Patients With Malignant Pleural Effusion: Protocol of PLEURAM Study

Thoracic Cancer - Australia
doi 10.1111/1759-7714.13279

Related search